Pituitary deficiency and precocious puberty after childhood severe traumatic brain injury: a long-term follow-up prospective study.


Journal

European journal of endocrinology
ISSN: 1479-683X
Titre abrégé: Eur J Endocrinol
Pays: England
ID NLM: 9423848

Informations de publication

Date de publication:
01 May 2019
Historique:
received: 16 01 2019
accepted: 07 03 2019
pubmed: 19 3 2019
medline: 8 5 2019
entrez: 19 3 2019
Statut: ppublish

Résumé

Objectives Childhood traumatic brain injury (TBI) is a public health issue. Our objectives were to determine the prevalence of permanent pituitary hormone deficiency and to detect the emergence of other pituitary dysfunctions or central precocious puberty several years after severe TBI. Design Follow-up at least 5 years post severe TBI of a prospective longitudinal study. Patients Overall, 66/87 children, who had endocrine evaluation 1 year post severe TBI, were included (24 with pituitary dysfunction 1 year post TBI). Main outcome measures In all children, the pituitary hormones basal levels were assessed at least 5 years post TBI. Growth hormone (GH) stimulation tests were performed 3-4 years post TBI in children with GH deficiency (GHD) 1 year post TBI and in all children with low height velocity (<-1 DS) or low IGF-1 (<-2 DS). Central precocious puberty (CPP) was confirmed by GnRH stimulation test. Results Overall, 61/66 children were followed up 7 (5-10) years post TBI (median; (range)); 17/61 children had GHD 1 year post TBI, and GHD was confirmed in 5/17 patients. For one boy, with normal pituitary function 1 year post TBI, GHD was diagnosed 6.5 years post TBI. 4/61 patients developed CPP, 5.7 (2.4-6.1) years post-TBI. Having a pituitary dysfunction 1 year post TBI was significantly associated with pituitary dysfunction or CPP more than 5 years post TBI. Conclusion Severe TBI in childhood can lead to permanent pituitary dysfunction; GHD and CPP may appear after many years. We recommend systematic hormonal assessment in children 1 year after severe TBI and a prolonged monitoring of growth and pubertal maturation. Recommendations should be elaborated for the families and treating physicians.

Identifiants

pubmed: 30884465
doi: 10.1530/EJE-19-0034
pii: EJE-19-0034
doi:
pii:

Substances chimiques

Human Growth Hormone 12629-01-5
Adrenocorticotropic Hormone 9002-60-2
Thyrotropin 9002-71-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

281-290

Auteurs

Yamina Dassa (Y)

Paediatric Endocrinology, Gynaecology and Diabetology Unit, Assistance Publique-Hôpitaux de Paris, Necker Enfants-Malades University Hospital, Paris, France.

Hélène Crosnier (H)

Paediatric Endocrinology, Gynaecology and Diabetology Unit, Assistance Publique-Hôpitaux de Paris, Necker Enfants-Malades University Hospital, Paris, France.

Mathilde Chevignard (M)

Rehabilitation Department for Children and Adolescents with Acquired Neurological Injury, Saint-Maurice Hospitals, Saint-Maurice, France.
Laboratoire d'Imagerie Biomédicale and GRC HanCRe, Sorbonne University, Paris, France.

Magali Viaud (M)

Paediatric Endocrinology, Gynaecology and Diabetology Unit, Assistance Publique-Hôpitaux de Paris, Necker Enfants-Malades University Hospital, Paris, France.

Claire Personnier (C)

CHI Poissy-St Germain, Poissy, France.

Isabelle Flechtner (I)

Paediatric Endocrinology, Gynaecology and Diabetology Unit, Assistance Publique-Hôpitaux de Paris, Necker Enfants-Malades University Hospital, Paris, France.

Philippe Meyer (P)

Paediatric Anaesthesiology Unit, Assistance Publique-Hôpitaux de Paris, Necker Enfants-Malades University Hospital, Paris, France.
Paris Descartes University, Paris, France.

Stéphanie Puget (S)

Paris Descartes University, Paris, France.
Paediatric Neurosurgery Unit, Assistance Publique-Hôpitaux de Paris, Necker Enfants-Malades University Hospital, Paris, France.

Nathalie Boddaert (N)

Paris Descartes University, Paris, France.
Radiology Unit, Assistance Publique-Hôpitaux de Paris, Necker Enfants-Malades University Hospital, Paris, France.

Sylvain Breton (S)

Radiology Unit, Assistance Publique-Hôpitaux de Paris, Necker Enfants-Malades University Hospital, Paris, France.

Michel Polak (M)

Paediatric Endocrinology, Gynaecology and Diabetology Unit, Assistance Publique-Hôpitaux de Paris, Necker Enfants-Malades University Hospital, Paris, France.
Paris Descartes University, Paris, France.
IMAGINE Institute Affiliate, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH